Chemicea Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.76 Cr
About Chemicea Pharmaceuticals
Chemicea Pharmaceuticals Private Limited (CPPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 July 2016 (Eight years and seven months 3 days old ). Its registered office is in Raigarh, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.76 Cr.
Deepak Pawar and Santosh Chindhe serve as directors at the Company.
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24290MH2016PTC402262
- Company No.
165628
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jul 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
What products or services does Chemicea Pharmaceuticals Private Limited offer?
Chemicea Pharmaceuticals Private Limited offers a wide range of products and services, including Brain & Nervous System Drugs, Antidepressant & Anti Anxiety Medicines, Anti Infective Drugs & Medicines, Antibacterial Drugs, Research and Development (R&D) Work, Product Development Research, Chemical Reagents & Catalysts, Fatty Esters, Pharma Ingredients & Raw Materials, Anti Inflammatory and Immunosuppressant API.
Who are the key members and board of directors at Chemicea Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Santosh Chindhe  | Director | 21-Jul-2016 | Current |
| Deepak Pawar | Director | 21-Jul-2016 | Current |
Financial Performance of Chemicea Pharmaceuticals.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chemicea Pharmaceuticals?
Unlock access to Chemicea Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹17.63 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.76 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Aug 2024 | Others | ₹9.50 M | Open |
| 12 Aug 2024 | Others | ₹7.00 M | Open |
| 31 Dec 2021 | Others | ₹1.13 M | Open |
How Many Employees Work at Chemicea Pharmaceuticals?
Unlock and access historical data on people associated with Chemicea Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemicea Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemicea Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
